Screening For Asymptomatic Obstructive Coronary Artery Disease Among High-Risk Diabetic Patients Using CT Angiography, Following Core 64 (faCTor-64)
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Patients with a known history of diabetes mellitus and no prior documented evidence of cardiovascular disease will be evaluated for inclusion in the study. Once qualified, patients will be enrolled and be randomized to either the Control Arm or to the Asymptomatic Screening Arm. Patients in the Control Arm will be followed by their primary care physicians with the recommendation that they follow standard guidelines for management of diabetic patients.
Patients in the Asymptomatic Screening Arm will undergo CT screening for either coronary calcium scoring or multi-slice CT angiography as well as be placed on one of two medical regimens. Patients will be followed by telephone at six-month intervals for two years for both primary and secondary outcomes.
| Condition | Intervention |
|---|---|
|
Coronary Artery Disease |
Procedure: CT Angiography |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Factorial Assignment Masking: Open Label Primary Purpose: Prevention |
| Official Title: | Screening For Asymptomatic Obstructive Coronary Artery Disease Among High-Risk Diabetic Patients Using CT Angiography, Following Core 64: A Randomized Control Study (The faCTor-64 Study) |
- The combination of all cause death, non-fatal MI, and hospitalization for unstable angina. [ Time Frame: 2-years ] [ Designated as safety issue: No ]
- 1. CV death 2. Hospitalization for heart failure 3. Worsening renal failure (progression of serum creatinine by ≥0.5 mg/dL 4. Stroke or carotid revascularization procedure 5. Limb amputation or peripheral vascular disease [ Time Frame: 2-years ] [ Designated as safety issue: No ]
| Estimated Enrollment: | 1100 |
| Study Start Date: | June 2007 |
| Estimated Study Completion Date: | December 2014 |
| Estimated Primary Completion Date: | June 2014 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
No Intervention: 1
Standard of Care
|
|
|
2
CT Angiography
|
Procedure: CT Angiography
If results indicate blockage, patients will receive interventional assessment (i.e., angiography) and treatment if indicated. All patients will receive aggressive treatment for type II diabetes (hemoglobin A1C) and lipids.
|
Show Detailed Description
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Age: Males ≥ 50 years; Females ≥55 years with: History of diabetes mellitus (prior documentation of fasting glucose ≥ 126 mg/dl or hemoglobin A1C > 6.5%), either type 1 or type 2, documented for at least 3 years and on medication for at least one year.
- Age: Males ≥ 40 years; Females ≥45 years with: History of diabetes mellitus (prior documentation of fasting glucose ≥ 126 mg/dl or hemoglobin A1C > 6.5%), either type 1 or type 2, documented for at least 5 years and on medication for at least one year.
- The patient or legally authorized representative must sign a written informed consent, prior to the procedure, using a form that is approved by the local Institutional Review Board.
Exclusion Criteria:
- Known coronary artery disease (stenosis >70%, history of myocardial infarction, or angina)
- Symptomatic cerebral vascular disease (history of TIA, CVA, or cerebrovascular [carotid or cerebral arteries] revascularization)
- Symptomatic peripheral vascular disease (history of claudication, amputation, or peripheral [including renal arteries] arterial revascularization)
- Treatment with any other investigational drug within the previous 30 days
- Any therapy or condition that would pose a risk to the patient or make it difficult to comply with study requirements.
- Pregnant and/or lactating women, and women of child bearing potential not using acceptable means of contraception. Women of childbearing potential must be using adequate measures of contraception (as determined by the Investigator) to avoid pregnancy and should be highly unlikely to conceive during the study period. Women of childbearing potential must have a negative pregnancy test at screen.
Any life threatening condition/significant co-morbidity such that primary screening is inappropriate.
-
Contacts and Locations| Contact: Joseph B Muhlestein, MD | 801-507-4760 | Brent.Muhlestein@imail.org |
| Contact: Jeffrey L Anderson, MD | 801-507-4757 | Jeffrey.Anderson@imail.org |
| United States, Utah | |
| Intermountain Healthcare | Recruiting |
| Salt Lake City, Utah, United States, 84143 | |
| Contact: Joseph B Muhlestein, MD 801-507-4760 Brent.Muhlestein@imail.org | |
| Contact: Jeffrey L Anderson, MD 801-507-4757 Jeffrey.Anderson@imail.org | |
| Sub-Investigator: Jeffrey L Anderson, MD | |
| Sub-Investigator: Donald L Lappe, MD | |
| Sub-Investigator: João AC Lima, MD | |
| Sub-Investigator: Steven Towner, MD | |
| Principal Investigator: | Joseph B Muhlestein, MD | Intermountain Health Care, Inc. |
More Information
No publications provided
| Responsible Party: | Intermountain Health Care, Inc. |
| ClinicalTrials.gov Identifier: | NCT00488033 History of Changes |
| Other Study ID Numbers: | 128-026 |
| Study First Received: | June 15, 2007 |
| Last Updated: | January 3, 2013 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by Intermountain Health Care, Inc.:
|
Coronary Artery Disease Diabetes CT Angiography |
Additional relevant MeSH terms:
|
Coronary Artery Disease Myocardial Ischemia Coronary Disease Heart Diseases |
Cardiovascular Diseases Arteriosclerosis Arterial Occlusive Diseases Vascular Diseases |
ClinicalTrials.gov processed this record on May 22, 2013